SCHEMBL29789803

SCHEMBL29789803

Cn1ccnc1-c1ccc2c(c1)NC(C)(C)C=C2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 2/20 0.34
▸ CDK8 P49336 2/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ HDAC4 P56524 2/20 0.34
▸ NMT1 P30419 1/20 0.33
▸ ACLY P53396 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ KDM5B Q9UGL1 1/20 0.32
▸ CHRM5 P08912 1/20 0.31
▸ CHRM1 P11229 1/20 0.31
▸ RIPK2 O43353 1/20 0.31
▸ LRRK2 Q5S007 1/20 0.31
▸ BACE1 P56817 1/20 0.31
▸ BACE2 Q9Y5Z0 1/20 0.31
▸ PDK1 Q15118 2/20 0.31
▸ PDK2 Q15119 2/20 0.31
▸ PDK3 Q15120 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123280 1.00 CCNC (0.34) CCNCCDK8PIK3CDPIK3CAPIK3CB
SCHEMBL29789952 0.73 PDK2 (0.36) PIK3CDPIK3CAPIK3CGPDK2
SCHEMBL23123380 0.73 PDK2 (0.36) PIK3CDPIK3CAPIK3CGPDK2
SCHEMBL23123492 0.71 BRD4 (0.38) BACE1BACE2PGRBRD4
SCHEMBL29789762 0.71 BRD4 (0.38) BACE1BACE2PGRBRD4
SCHEMBL23123752 0.70 AR (0.41) CCNCCDK8PIK3CDPIK3CAPIK3CB
SCHEMBL29789713 0.70 AR (0.41) CCNCCDK8PIK3CDPIK3CAPIK3CB
SCHEMBL16984616 0.67 USP2 (0.45) CCNCCDK8HDAC4NMT1RIPK2
SCHEMBL23123305 0.67 QDPR (0.49) —
SCHEMBL29789821 0.67 QDPR (0.49) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901652-A Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for the treatment of medical disorders 比亚尔R&D投资股份公司 2022-08-12 — — CN disclosed
Send feedback